Valeant, a Canadian drug company, made a $5.7 billion hostile offer for Cephalon, a smaller American rival, and gave notice it wanted its own people to sit on Cephalon’s board.
加拿大制药公司，将以57亿美元收购一家较小规模的美国竞争对手Cephalon公司，同时发出通知，他们希望本国人民坐在Cephalon的董事会。
Valeant, a Canadian drug company, made a $5.7 billion hostile offer for Cephalon, a smaller American rival, and gave notice it wanted its own people to sit on Cephalon’s board.
加拿大制药公司，将以57亿美元收购一家较小规模的美国竞争对手Cephalon公司，同时发出通知，他们希望本国人民坐在Cephalon的董事会。
应用推荐